Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Environmental Compliance and Pharmaceutical Quality Standards Pave the Way for Transformational Growth in Chromatography 2024-08-13 01:30
OcuMension acquires rights to Alcon eye drops in exchange for a 16.7% equity stake, signaling the commencement of comprehensive strategic relationship 2024-08-12 22:01
Ocumension (01477.HK) Demonstrates Strong Operational Resilience, Commercialization Capabilities Reach New Heights 2024-08-12 21:52
Alphamab Oncology to Present the Latest Clinical Data of Anti-HER2 Bispecific ADC JSKN003 at the ESMO Congress 2024 2024-08-12 10:18
Docquity Drives Demand for SIT Pharma's Duo Probiotics in Thailand, Achieving 31% Sales Growth in 6 months 2024-08-07 10:05
GSK's Jemperli (dostarlimab) plus chemotherapy approved in Singapore as the first frontline immuno-oncology treatment for dMMR/MSI-H primary advanced or recurrent endometrial cancer 2024-08-07 09:00
Latest Updates of Viva Biotech's Portfolio Companies 2024-08-06 18:47
First patient enrollment in the U.S. - A milestone for the global multi-center phase Ⅲ clinical trial of telitacicept for myasthenia gravis 2024-08-06 17:00
Antengene Announces XPOVIO® (selinexor) Approved for Commercialization in Malaysia 2024-08-06 08:00
Everest Medicines to Announce 2024 Interim Results on August 28, 2024 2024-08-06 07:30
Seegene Showcased its Multiplex Technology at ADLM 2024 2024-08-05 21:00
DKSH and Kyowa Kirin Forge Strategic Partnership Across Asia-Pacific 2024-08-05 10:34
Innovent and SanegeneBio Announce First Participant Dosed in a Phase 1 Clinical Trial of IBI3016 (AGT siRNA) 2024-08-02 08:37
Innovent Announces the NDA of Mazdutide for Type 2 Diabetes has been Accepted by the NMPA of China 2024-08-01 16:40
Biosyngen Partners with Singapore's Agency for Science, Technology and Research (A*STAR) to Advance Autoimmune Therapy 2024-08-01 16:01
Sirnaomics Announces a Partnership with Gore Range Capital for Establishment of a JV, Sagesse Bio, to Advance Its RNAi Therapeutics into Aesthetic Medicine 2024-08-01 11:26
Sirnaomics Announces a Partnership with Gore Range Capital for Establishment of a JV, Sagesse Bio, to Advance Its RNAi Therapeutics into Aesthetic Medicine 2024-08-01 09:35
Prestige Biopharma's Herceptin Biosimilar Tuznue® Receives Positive CHMP Opinion from the EMA 2024-08-01 08:00
Kexing Biopharm's Albumin-bound Paclitaxel Granted EU Market Approval 2024-07-31 18:33
Connext Successfully Administers First Dose of CNT201 for Dupuytren's Contracture 2024-07-30 21:00
1 8 9 10 11 12 247